OpenAI IPO Delay Sends Morgan Stanley and Goldman Sachs Shares Lower as AI-Linked Deal Optimism Cools

Keywords: OpenAI, IPO delay, Morgan Stanley, Goldman Sachs, AI capital markets, investment banking, technology stocks, KBW Bank Index, equity markets

Introduction

On Friday morning, shares of Morgan Stanley and Goldman Sachs came under notable pressure in U.S. pre-market and early trading, as investors reacted to reports that OpenAI may postpone its long-anticipated initial public offering. The two Wall Street giants, both widely viewed as potential beneficiaries of a major AI-related listing wave, fell sharply at the open before trimming some losses. The broader banking sector also weakened, with the KBW Bank Index slipping as market sentiment toward capital-markets activity softened.

The move highlights how closely investment banks have become tied to the AI theme. In recent months, expectations for blockbuster listings, private placements, and strategic financing tied to leading artificial intelligence firms have helped support optimism around dealmaking revenues. A delay in one of the industry’s most closely watched IPOs is therefore being interpreted not just as a company-specific development, but as a signal that the broader AI capital-markets pipeline may take longer to materialize than previously expected.

OpenAI Delay Weighs on Bank Shares

At the start of trading on June 26, Morgan Stanley briefly fell around 4.2% to $211.84, while Goldman Sachs dropped as much as 4.8% to $1,013.38, both hitting their lowest levels since June 12. The KBW Bank Index declined more than 1.6% intraday, reflecting broader selling across financial stocks.

The pressure followed reports that OpenAI is considering delaying its IPO from this fall to next year due to volatility in the technology stock market. OpenAI had reportedly been working with Morgan Stanley and Goldman Sachs on a potential listing, and the prospect of a high-profile debut had fed expectations that major banks would secure lucrative underwriting, advisory, and related capital-markets fees.

OpenAI has also previously engaged with other large institutions, including Citigroup and JPMorgan Chase, to discuss participation in its listing plans. Meanwhile, its rival Anthropic has selected Morgan Stanley and Goldman Sachs to lead its IPO process, with JPMorgan also said to be involved. Against that backdrop, OpenAI’s possible delay is being read by investors as a temporary setback to what had been shaping up as a meaningful catalyst for Wall Street’s capital-markets businesses.

Why the Market Reacted So Quickly

The market’s response reflects more than a simple reaction to a delayed IPO. For investors, OpenAI represents a flagship name in the AI ecosystem — one with the brand recognition, growth narrative, and potential valuation scale capable of reshaping expectations for the entire tech listings landscape. If a company of that profile waits, investors may infer that management teams across the sector are becoming more cautious about market timing.

That caution matters. IPO markets are highly sensitive to sentiment, especially for richly valued technology companies. When public-market volatility increases, firms often prefer to wait rather than risk a weak debut, limited demand, or a lower-than-expected valuation. In OpenAI’s case, reports suggest that the company has not yet held formal pre-IPO meetings focused on pricing or demand and has not set a firm listing timetable. In other words, the delay does not necessarily signal a change in long-term intent, but rather a pragmatic response to market conditions.

Still, for banks that have been positioning themselves as key beneficiaries of the AI investment cycle, even a postponement can dent near-term revenue expectations. A major listing can generate substantial fees, but it can also help stimulate follow-on offerings, private transactions, trading activity, and broader client engagement. When such a deal slips, the ripple effects extend beyond a single mandate.

Morgan Stanley and Goldman Still Have Strong Momentum

Despite the setback, it is important to note that both Morgan Stanley and Goldman Sachs remain in strong year-to-date uptrends. Morgan Stanley has gained more than 30% this quarter, while Goldman Sachs is up over 22%, helped in part by their role in the so-called “epic IPO” of SpaceX and the broader optimism surrounding AI-related capital formation.

Analysts have emphasized that this recent weakness should be viewed in context. Herman Chan noted that Goldman Sachs and Morgan Stanley lagged peers on the day, but both banks have been among the biggest beneficiaries of enthusiasm around AI-driven capital-markets activity. Their lead roles in major deals have reinforced the market’s view that they are well positioned to monetize the next wave of innovation.

That said, the market is notoriously forward-looking. When a high-profile deal is delayed, investors quickly reassess whether the expected flow of fees will arrive on the original timetable. Even if the long-term opportunity remains intact, timing can matter significantly to quarterly and annual earnings estimates.

Broader Implications for the IPO Market

Truist analyst Brian Finneran wrote that the news has not only weighed on technology stocks but also prompted questions about whether the optimistic outlook for firms such as Goldman Sachs and Morgan Stanley could be disrupted. That concern is understandable, especially after a period in which the market had grown increasingly confident that a wave of AI-related listings would boost underwriting activity.

Yet there is an important counterpoint. Finneran also argued that the IPO market remains open and that staggering listings could actually support 2027 results by reducing the risk of difficult year-over-year comparisons. In other words, a delay may shift fee income rather than destroy it. If market conditions improve next year, OpenAI’s debut could potentially command stronger demand, better pricing, and a more stable reception.

This is a key distinction for investors. A postponed IPO does not necessarily mean a diminished IPO. For banks, the difference between launching in a volatile window and waiting for a more favorable one can be material. In some cases, patience may ultimately lead to a better outcome for both the issuer and its underwriters.

Conclusion

The decline in Morgan Stanley and Goldman Sachs shares underscores how tightly Wall Street’s fortunes have become linked to the AI investment cycle. OpenAI’s potential IPO was seen as a milestone event — not only for the company itself, but for the broader market narrative around artificial intelligence, innovation, and capital formation. A possible delay has therefore been enough to unsettle investors and pressure bank stocks, even as both firms remain strong performers over the broader quarter.

Ultimately, the episode serves as a reminder that IPO timing is a strategic decision shaped by market conditions as much as by company ambition. While the near-term impact may be negative for sentiment, the long-term case for AI-related capital markets activity remains intact. If anything, the delay may simply be a sign that one of the most anticipated listings of the year is waiting for a better stage.